Browse by Medical Category
Go To Programs
Go To Specialties
As Director of Thoracic Imaging and Intervention at the Massachusetts General Hospital, and Professor of Radiology at Harvard Medical School, Dr. Jo-Anne Shepard assumes responsibility for all clinical, teaching and research activities within the Division. Dr. Shepard provides subspecialty diagnostic consultation on a wide spectrum of surgical and medical patients including critical care patients in the Cardiac Care Unit (CCU), Cardiac Surgical Intensive Care Unit (SICU), Surgical Intensive Care Unit (SICU), Neurologic Intensive Care Unit, and Medical Intensive Care Unit (MICU). In addition, she provides imaging and consultation for critically ill patients on the transplant, oncology, burn, trauma, infectious disease, and pulmonary services in addition to the general medical and surgical services. Dr. Shepard routinely performs diagnostic percutaneous biopsy of the lung and she has instituted radiofrequency ablation (RFA) as an alternative treatment for tumors of the lung and chest wall with the support of the Departments of Thoracic Surgery and Thoracic Oncology. As Medical Director, Department of Radiology, Spaulding Rehabilitation Hospital, Dr. Shepard has administrative responsibility for the technical performance and diagnostic interpretation of the radiographic images performed in the department.Dr. Shepard teaches the art and science of radiology to Harvard medical students, medical, surgical and radiology interns, residents and fellows and international visiting physicians. She is Director of the Cardiothoracic Imaging Fellowship Program at Massachusetts General Hospital and an examiner in Cardiothoracic Radiology for the American Board of Radiology (ABR). Since 2000 she has been Associate Editor in Radiology for the Case Records of the Massachusetts General Hospital, New England Journal of Medicine.Dr. Shepard's research interests are in the realm of thoracic imaging and intervention.
November is Lung Cancer Awareness Monthand Jo-Anne Shepard, MD, Director of MGH Thoracic Imaging and Intervention, would like to share important information about the only lung cancer screening test proven to decrease mortality from this devastating illness.
With implications for insurance coverage, the U.S. Preventive Services Task Force recommends annual low-dose CT scans to reduce lung cancer deaths.
Director of Thoracic Imaging and Intervention in the Mass General Department of Radiology, Dr. Jo-Anne Shepard explains what the recent lung cancer screening recommendations mean for patients.
On July 29, the U.S. Preventive Services Task Force (USPSTF) announced its recommendation for screening high-risk patients for lung cancer with low-dose CT scans (LDCTs).
The U.S. Preventive Services Task Force recommends low-dose CT scans to screen high-risk patients for lung cancer.
During the fifth annual physician recognition dinner hosted Nov. 12 by the Massachusetts General Physicians Organization (MGPO), nearly 600 physicians and guests gathered to celebrate the past, present and future of MGH's clinical contributions and to honor the memory of the late cardiologist Brian A. McGovern, MD, with the presentation of three awards in his name.
Research shows a clear benefit for CT lung-cancer screening among individuals who meet strict criteria. Patients and referrers should understand both the benefit and the potential for false positive results.
An image processing technique called ASIR allows radiologists to reduce radiation levels in chest CT exams without sacrificing image quality or diagnostic confidence, according to a paper just published by Mass General researchers.
Back to Top